A program of outpatient parenteral antibiotic therapy for serious pediatric bacterial infections

R Dagan1, M Einhorn

  • 1Pediatric Infectious Disease Unit, Soroka Medical Center, Beer Sheva, Israel.

Insights

Outpatient parenteral antibiotic therapy (OPAT) for pediatric serious bacterial infections achieved a 98.5% cure rate. This program significantly reduced hospital stays, saving 1,334 days for 140 children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Serious bacterial infections in children often require prolonged hospitalization.
  • Outpatient parenteral antibiotic therapy (OPAT) presents a potential alternative to inpatient care.
  • Establishing effective OPAT programs requires careful patient selection and logistical support.

Purpose of the Study:

  • To evaluate the efficacy and impact of an established pediatric OPAT program.
  • To assess the feasibility and outcomes of treating serious pediatric bacterial infections via OPAT.
  • To determine the resource utilization and cost-effectiveness of the OPAT program.

Main Methods:

  • Implementation of a pediatric OPAT program at Soroka University Medical Center.
  • Inclusion criteria: suitable infection, available antibiotic (ceftriaxone IM), informed parents, 24/7 home-hospital communication and transport.
  • Data collection on cure rates, hospital days saved, and patient numbers over 17 months.

Main Results:

  • The OPAT program achieved a high cure rate of 98.5%.
  • Significant reduction in hospital resource utilization, with an estimated 1,334 hospital days saved.
  • The program successfully managed 140 pediatric patients over a 17-month period.

Conclusions:

  • Pediatric OPAT, utilizing ceftriaxone, is a highly effective treatment strategy for serious bacterial infections.
  • OPAT offers substantial benefits in reducing hospital length of stay and associated healthcare costs.
  • The program demonstrates the viability of transitioning pediatric care from inpatient to outpatient settings under specific conditions.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...